期刊文献+

乳腺癌高危妇女的评估与预防策略 被引量:50

Assessment and prevention of high risk women with breast cancer
下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤之一。流行病学研究发现乳腺癌有许多高危因素 ,其中最主要的因素包括年龄、乳腺癌家庭史和既往某些乳腺疾病史。对于乳腺癌的高危人群开展预防工作是目前的一项重要课题 ,常用的方法包括预防性乳腺切除术、严密监测和化学预防。多项研究表明预防性乳腺切除术不能百分之百起到预防效果 ;乳房切除容易给妇女带来严重的精神创伤 ,因而必须严格掌握手术指证 ,术后也宜首选即刻乳房重建。严密监测应包括定期乳腺X线摄片和临床体检 ,前者已证实具有明显的早期诊断价值 ;有关化学预防试剂的随机对照研究已有初步结果 ,三苯氧胺能显著降低乳腺癌高危人群的乳腺癌发生率 ,相关的其他临床研究还在进行之中。总之乳腺癌高危人群的预防策略应首先基于患者危险性的高低 ,病人对危险性以及各项预防措施的看法应当得到重视 。 Breast cancer is one of the most common malignancies in women. The epidemiological study suggests that the development of female breast cancer is related to dozens of risk factors, among which age,family history of breast cancer and anamnesis of some breast diseases are three most important ones. Therefore, prophylactic measures for high risk women have become a significant subject. Today the preventive methods include prophylactic mastectomy, strict surveillance and chemoprevention. Many researches demonstrated preventive surgery is not absolutely reliable; women without breasts may develop psychosis and for this reason the indication must be defined carefully and a following immediate reconstruction of breast should be considered. The strict surveillance consists of regular mammography and clinical examination. The recent ongoing clinical trials on chemoprevention drugs have preliminary results, NSABP 01 showed that Tamoxifen could effectively reduce the incidence of breast cancer after 7 years follow up. In conclusion, the preventive strategy for high risk women should be based on the graveness of the risks. The patient's attitude for her risk factor and all preventive methods should be recognized by doctors when the choice is made ultimately.
出处 《中国癌症杂志》 CAS CSCD 2000年第5期438-442,共5页 China Oncology
关键词 乳腺癌 危险因素 预防 breast cancer risk factors prevention
  • 相关文献

参考文献10

  • 1[1]HarrisJR, Morrow M, Bonadonna G. Cancer of the breast, in Devita JR, Hellman S, Rosenberg SA(eds):Cancer Principle and Practice of Oncology[JM],ed 5. Philadelphia,JB Lippincott CO,1997:1264-1332.
  • 2[2]Jordan VG, Morrwo M. An appraisal of strategies to reduce the incidence of breast cancer[J].Stem Cells,1993,11(4):252-262.
  • 3[3]King MC, Rowell S, LoveSM. Inherited breastand ovarian cancer:What arethe risks? What are the choices?[J].JMMA,1993,269(15):1975-1980.
  • 4[4]Morrow M.Pre-cancerous breast cancer lesions:implications forbreast cancer prevention trials[J].Int J Radiat Oncol Biol Phys, 1992,23(5):1071-1078.
  • 5[5]Ottesen GL, Graversen HP, Blichert-Toft, et al. Lobular carcinoma in stiu of the female brest. The Danish Breast Cancer Cooperative Group:Short tem results of prospective nationwide study[J].Am J Surg Pathol,1993,17(1):14-21.
  • 6[6]Bondy SML, Lustbsder ER, halabi S, et al. Validation of a breast cancer risk assessment model in women with a positive family history[J].J Natl Cancer nst,1994,86(8):620-625.
  • 7[7]Gail J, BrintonLA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually[J].J Natl Cancer Inst,1989,81(24):1879-1886.
  • 8[8]Bostwick J 3d, Jones G. Why I Choose autogenous tissue in breast reconstruction[J].Clin Plast Surg,1994,21(2):165-175.
  • 9[9]Fisher B, Costantino JP, Wickerham DL, etal. Tamoxifen for prevention of breast cancer:report of the national surgical adjuvant breast and bowel project P-1 sutdy[J].J Natl Cancer Inst,1998,90(18):1371-1388.
  • 10[10]Morrow M, Quiet C, Hellman S, et al. Treatment selection in breast cancer:are our biases correct?[J] Proceedings of american society of clinical oncologists,1994,13:99-100.

同被引文献289

引证文献50

二级引证文献268

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部